Jerusalem, Israel

David Lerner


Average Co-Inventor Count = 6.8

ph-index = 14

Forward Citations = 525(Granted Patents)


Company Filing History:


Years Active: 1995-2013

Loading Chart...
17 patents (USPTO):Explore Patents

Title: Innovations by David Lerner in Pharmaceutical Development

Introduction

David Lerner, an esteemed inventor based in Jerusalem, IL, has made significant contributions to the field of pharmaceuticals with a total of 17 patents to his name. His work primarily focuses on the development of innovative compounds for therapeutic uses, particularly in the treatment of Alzheimer's disease.

Latest Patents

Among his latest innovations, Lerner has created a groundbreaking method for treating individuals identified as having Alzheimer’s disease. This involves administering a therapeutically effective amount of ladostigil or its pharmaceutically active salts orally. The recommended doses range from 70 mg per day to 200 mg per day. Additionally, he has developed unit dosage forms of ladostigil in amounts of 50 mg, 70 mg, 80 mg, or 100 mg. This collection of patents around propargylated aminoindans illustrates his commitment to advancing healthcare solutions.

Career Highlights

David Lerner's career has seen him collaborating with prominent companies such as Teva Pharmaceutical Industries Limited and the Technion Research & Development Foundation Limited. These affiliations underscore his active engagement in pharmaceutical innovation and research.

Collaborations

Throughout his career, Lerner has worked alongside notable colleagues, including Jeffrey Sterling and Ruth Levy. Their collaborations likely provided a platform for sharing ideas and accelerating the development of important pharmaceutical technologies.

Conclusion

David Lerner continues to be a pivotal figure in the realm of pharmaceutical inventions. His innovative work, particularly concerning the treatment of Alzheimer's disease, reflects a profound dedication to improving patient outcomes through scientific advancements. As the healthcare landscape evolves, his contributions will likely play a crucial role in shaping future therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…